Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-06
2008-05-06
Coleman, Brenda L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S063000, C514S213010, C540S487000, C540S523000, C540S593000
Reexamination Certificate
active
10504422
ABSTRACT:
The present invention relates to the compound presented by formula (I)(wherein all symbols in formula (I) are the same mean as the description shown in the specification.), mitocondorial benzogeazepin receptor (MBR) antagonist comprising the compound, the preventive and/or treatment medicine against diseases caused by stress of which an active ingredient is the compound.Since the compound represented by formula (I) has MBR antagonistic activity, and controls the production of neurosteroid, it is useful as the preventive and/or treatment medicine against diseases caused by stress.
REFERENCES:
patent: 3346565 (1967-10-01), Testa et al.
patent: 3395150 (1968-07-01), Krapcho
patent: 3458498 (1969-07-01), Koo et al.
patent: 3516987 (1970-06-01), Koo et al.
patent: 3542760 (1970-11-01), Koo et al.
patent: 3748321 (1973-07-01), Krapcho et al.
patent: 3960876 (1976-06-01), Curran
patent: 4029667 (1977-06-01), Curran
patent: 1473839 (1967-03-01), None
patent: 1193534 (1970-06-01), None
patent: WO 01/32610 (2001-05-01), None
patent: WO 03/030937 (2003-04-01), None
Khanna, J.M. et al, Agents Acting on the Central Nervous System. X. 1-Substituted 3-Phenyll-2,2,3,4.5-tetrahydro-1H-1benzazepines, Journal of Medicinal Chemistry, 1967, No. 395, vol. 10, pp. 944 to 945.
Beattle, Doreen E. et al., 5,6,7,8- Tetrahydroquinolines.5. Antiulcer and Antisecretory Activity of 5,6,7,8-Tetrahydroquinolinethioureas and Related heterocycles, Journal of Medicinal Chemistry, 1977, vol. 20, No. 5, pp. 718 to 721.
Ishihara, Yuji et al., Regioselective Friedel-Crafts Acylation of 1,2,3,4-Tetrahydroquinoline and Related Nitrogen Heterocycles: Effects of NH Protective Groups and Ring Size, J. Chem. Soc. Perkin Trans., 1, 1992, vol. 24, pp. 3401 to 3406.
Yanagida, A. Jossang et al., Derivatives of 2,3,4,5-tetrahydroo-1H-pyriodo[3,2-b] azapine and their corresponding lactams. II. Synthesis and pharmacological study on their psychotropic activity, Farmaco, Edizione Scientifica, 1979, vol. 34, No. 1, pp. 26 to 35.
Yanagida, A. Jossang et al., Derivatives of tetrahydropyrido azepines and tetrahydropyridoazepineones. I. Derivatives of 2,3,4,5-tetrahydro-1H-pyrido[3,2-b] azepine and the corresponding lactam, Farmaco, Edizione Scientifica, 1978, vol. 33, No. 12, pp. 984 to 991.
Testa, E. et al., Substances active on the nervous system. XXXVIII. Synthesis of 5-phenyl-3,5-dihydro-4,1-benzoazepin-2(1H)-ones and 5-phenyl.2.3.5-tetrahydro-4,1-benzoxazepines, Farmaco(Pavia), Ed. Sci., 1963, vol. 18, No. 11, pp. 815 to 827.
Dodd, Rober H. et al., Modifications of Mitochondrial Benzodiazephine Receptor Numbers in Stressful Situations, Peripher. Benzodiazepine Recept., 1993, pp. 187 to 207.
Kato Masashi
Katsumata Seishi
Manako Jun-ichiro
Ohmoto Kazuyuki
Seko Takuya
Coleman Brenda L
Ono Pharmaceutical Co. Ltd.
LandOfFree
N-carbamoyl nitrogen-containing fused ring compounds and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-carbamoyl nitrogen-containing fused ring compounds and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-carbamoyl nitrogen-containing fused ring compounds and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3906519